Abbot Financial Management’s Medtronic MDT Stock Holding History

Abbot Financial Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Buy	4,418 +82	+2%	+$6.62K	0.12%	118
2026 Q1	$376K	Buy	4,336 +42	+1%	+$4.02K	0.16%	114
2025 Q4	$412K	Hold	4,294	–	–	0.17%	112
2025 Q3	$409K	Sell	4,294 -950	-18%	-$87.3K	0.17%	109
2025 Q2	$457K	Hold	5,244	–	–	0.21%	100
2025 Q1	$471K	Buy	5,244 +17	+0.3%	+$1.52K	0.24%	98
2024 Q4	$418K	Sell	5,227 -300	-5%	-$26K	0.21%	101
2024 Q3	$498K	Hold	5,527	–	–	0.25%	100
2024 Q2	$435K	Buy	5,527 +100	+2%	+$8.2K	0.23%	101
2024 Q1	$473K	Buy	+5,427	New	+$463K	0.26%	97

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Abbot Financial Management's MDT Position: Q2 2026 in Review

Abbot Financial Management increased its Medtronic (MDT) stake by 1.9% in Q2 2026, buying an estimated $6.62K and bringing the position to 4,418 shares worth $346K. The position accounts for 0.12% of the portfolio, ranked #118.

Abbot Financial Management first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $498K in Q3 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Abbot Financial Management held 4,418 shares of Medtronic worth $346K as of Q2 2026.
Abbot Financial Management bought 82 Medtronic shares in Q2 2026, an estimated $6.62K.
Medtronic made up 0.12% of Abbot Financial Management's portfolio in Q2 2026, its #118 holding.
Abbot Financial Management first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
Abbot Financial Management's Medtronic position peaked at $498K in Q3 2024.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Abbot Financial Management's 13F filing for Q2 2026, filed 6 Aug 2026.